文献速递美容整形

冻干同种异体骨用于鼻背增高的10年综合回顾

Nasal Dorsal Augmentation with Freeze-Dried Allograft Bone: 10-Year Comprehensive Review.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

本文报告冻干皮质同种异体骨用于鼻背增高的10年综合回顾,共62例患者,评估1至10年(平均4.7年),总体成功率为85%。客观影像学证实19例移植物中16例体积持久或血管化,43例中37例患者主观认为体积持久。作者认为该材料安全有效且无供区并发症,证据等级为IV级。

要点

  • 冻干同种异体骨鼻背增高10年总体成功率为85%(62例,平均随访4.7年)。
  • 影像学客观证实19例移植物中16例体积持久或新血管化。
  • 患者主观评估43例中37例认为体积持久。

核心结论

  • 冻干同种异体骨是鼻背增高安全且等效的替代方案,无供区并发症。
  • 需进一步研究证实年轻需长期重建患者的效果,并探索部分脱钙以便手术刀雕刻。

研究设计与样本

  • 10年综合回顾性研究,纳入62例患者,评估1至10年(平均4.7年)。
  • 移植物符合美国组织库协会、美国食品药品监督管理局和疾病控制与预防中心推荐标准。

主要发现

  • 客观影像学(头影测量X线、锥形束容积CT、CT)证实19例移植物中16例体积持久或新血管化。
  • 患者主观评估43例移植物中37例认为体积持久。
  • 62例患者总体成功率为85%,评估时间1至10年,平均4.7年。

关键数值与推荐

  • 总体成功率85%(62例,1-10年,平均4.7年)。
  • 客观体积持久或新血管化:16/19例移植物。
  • 患者主观体积持久:37/43例移植物。

临床怎么用

  • 冻干同种异体骨可作为鼻背增高材料,避免供区并发症。
  • 术前可告知患者10年总体成功率约85%,但证据等级为IV级。

局限性

  • 证据等级为IV级(治疗性)。
  • 作者指出需进一步研究证实年轻患者长期重建效果,并探索部分脱钙以便雕刻。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to evaluate freeze-dried cortical allograft bone for nasal dorsal augmentation. The 42-month report on 18 patients was published in 2009 in Plastic and Reconstructive Surgery with 89 percent success at level II evidence, and this article is the 10-year comprehensive review of 62 patients. METHODS: All grafts met standards recommended by the American Association of Tissue Banks, the U.S. Food and Drug Administration, and the Centers for Disease Control and Prevention. Objective evaluation of the persistence of graft volume was obtained by cephalometric radiography, cone beam volumetric computed tomography, and computed tomography at up to 10 years. Vascularization and incorporation of new bone elements within the grafts were demonstrated by fluorine-18 sodium fluoride positron emission tomography at up to 10 years. Subjective estimation of graft volume persisting up to 10 years was obtained by patient response to a query conducted by an independent surveyor. RESULTS: The authors report objective proof of persistence of volume alone or combined with proof of neovascularization in 16 of 19 allografts. The authors report the patient's subjective opinion of volume persistence in 37 of 43 grafts. The dorsal augmentation was assessed overall to be successful in 85 percent of 62 patients evaluated between 1 and 10 years, with a mean of 4.7 years. CONCLUSIONS: Freeze-dried allograft bone is a safe and equal alternative for dorsal augmentation without donor-site morbidity. Further studies are needed to (1) confirm these findings for young patients needing long-term reconstruction, and (2) partially demineralize allograft bone to allow carving with a scalpel. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Clark RP, Pham PM, Ciminello FS, et al. Nasal Dorsal Augmentation with Freeze-Dried Allograft Bone: 10-Year Comprehensive Review. Plast Reconstr Surg. 2019. PMID: 30589780. doi:10.1097/PRS.0000000000005166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。